Research progress of novel molecular probe PET/CT imaging in differentiated thyroid cancer
In recent years,the incidence of differentiated thyroid cancer(DTC)has been increasing significantly.The application of PET/CT in the integration of diagnosis and treatment of DTC has attracted much attention.It provides molecular information by combining anatomical with functional imaging.Fluorodeoxyglucose(18F-FDG)has been confirmed as a marker of cellular glucose metabolism and is the most widely used PET radiopharmaceutical.In addition to 18F-FDG,multiple new PET molecular probes are also expected to be applied from basic research to clinical practice for imaging and guiding treatment of DTC.This article reviews the mechanism and research progress of new PET molecular probes,aiming to provide valuable reference for the development and application of new molecular probes in the diagnosis and treatment of DTC.
differentiated thyroid cancernovel PET molecular probePET/CT
万方数据
维普
